Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | BIRC5 |
| Upstream (Parents) |
|---|
| (<<) CKS2 → BIRC5 |
| (<<) DLGAP5 → BIRC5 |
| Downstream (Children) |
|---|
| BIRC5 → CKS2 (>>) |
| BIRC5 → LRP8 (>>) |
| BIRC5 → DSCC1 (>>) |
| BIRC5 → CDC6 (>>) |
| BIRC5 → TK1 (>>) |
| BIRC5 → NCAPH (>>) |
| BIRC5 → CDC45 (>>) |
| BIRC5 → ORC1L (>>) |
| BIRC5 → CENPM (>>) |
| BIRC5 → CENPA (>>) |
| BIRC5 → CHEK1 (>>) |
| BIRC5 → DLGAP5 (>>) |
| BIRC5 → CDKN3 (>>) |
| BIRC5 → FUT4 (>>) |
| BIRC5 → UBE2S (>>) |
| BIRC5 → E2F1 (>>) |
| BIRC5 → KIF18B (>>) |
| BIRC5 → KIF20A (>>) |
| BIRC5 → SNHG3-RCC1///RCC1 (>>) |
| BIRC5 → BRCA1 (>>) |
| BIRC5 → MTHFD2 (>>) |
| BIRC5 → KIF2C (>>) |
| BIRC5 → FEN1 (>>) |
| BIRC5 → KHDC1///SPA17 (>>) |
| BIRC5 → KPNA2 (>>) |
| BIRC5 → KIAA0101 (>>) |
| BIRC5 → SLC7A5 (>>) |
| BIRC5 → HN1 (>>) |
| BIRC5 → PYCR1 (>>) |
